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Abstract
Background To evaluate the laparoscopic management of Mirizzi syndrome, seldom diagnosed preoperatively causing dif-
ficulty when performing cholecystectomy and increasing complication risks.
Methods Analysis of a prospective single-surgeon database of 5700 laparoscopic cholecystectomies found 58 Mirizzi 
syndrome cases. They were managed with an intention to treat during the index admission according to protocol of single-
session management of bile duct stones.
Results 38/58 patients were females (65.5%). The median age was 55 years. 53 cases were emergency admissions. 34 cases 
(58.6%) only had ultrasound scanning. Operative difficulty was Grade IV in 34 cases (58.6%) and Grade V in 20 (34.5%) 
(Nassar Scale). There were 33 Mirizzi Type IA, 7 Type IB, 16 Type II and one each of Type III and Type IV. Bile duct 
exploration was performed in 94.8% through choledochotomy/ transfistula in 58.6% or transcystic in 36.2%. Four cases 
required conversion to open. Postoperative morbidity occurred in 29%. Two 30-day mortalities occurred from pneumonia 
in two elderly patients who were late referrals.
Conclusion Although the utilization of the laparoscopic approach in managing bile duct stones is not currently widely 
practiced it was safer in this series than in reported series of open surgery in Mirizzi Syndrome. The optimal approach to 
Mirizzi Type II is via cholecystocholedochal fistula to explore the bile duct then drain with T-tube through the fistula. It is 
unnecessary to perform bilioenteric bypass in majority of cases, reducing the morbidity and mortality.
Keywords Laparoscopic cholecystectomy · Mirizzi syndrome · Difficulty grading
The adoption of single-session laparoscopic management of 
cases with suspected bile duct stones has clinical and cost 
advantages. It obviates the need for expensive, and some-
times invasive, preoperative diagnostic and therapeutic 
interventions. Although not widely practiced it has become 
accepted by most international endoscopic surgery societies 
and incorporated in their guidelines as the more optimal 
treatment where the expertise and logistics are available.
Mirizzi Syndrome (MS) is one of the most complex 
pathologies that can be encountered during laparoscopic 
cholecystectomy. It is associated with surgical difficulty, a 
high conversion rate, and high risk of operative complica-
tions, particularly bile duct injury.
The term Mirizzi Syndrome was popularized after the 
entity was described by an Argentinian surgeon, Pablo 
Mirizzi in 1948 [1]. The typical abnormality is an impac-
tion of a stone in the cystic duct, which lies parallel to the 
common hepatic duct resulting in its obstruction.
A simple classification was proposed by McSherry [2], 
suggesting the two types most commonly described; Type I 
resulting from extrinsic compression of the common hepatic 
duct by stones impacted in the cystic duct or the gallbladder 
infundibulum (Fig. 1) and Type II where a cholecystochole-
dochal fistula exists.
Csendes [3] classified Mirizzi Syndrome into four 
types, further dividing Type II according to the extent of 
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the involvement of the common hepatic duct wall in the 
McSherry’s Type II fistula.
Methods
We aim to evaluate our operative management of Mirizzi 
Syndrome (MS). Prospectively collected data were included 
in a database of 5740 laparoscopic cholecystectomies (LC), 
including 1314 bile duct explorations carried out between 
February 1992 and February 2020. All cases were performed 
by a single surgeon. The specialized biliary firm is dedicated 
to managing the great majority of biliary emergencies, and 
almost all suspected ductal stones, admitted under surgeons, 
physicians, or gastroenterologists in the hospital. It receives 
occasional patients from other hospitals for the purpose of 
laparoscopic ductal exploration. 58 cases of MS were man-
aged according to a standard protocol for suspected bile duct 
stones, based on single-session laparoscopic management 
during the index admission. Ultrasound scanning is the only 
routine preoperative imaging. MRCP and CT scanning are 
carried out occasionally and selectively, mainly when the 
ultrasound scan is negative for gallbladder stones in a jaun-
diced patient or when malignancy is suspected. ERCP is not 
part of our protocol for managing bile duct stones except in 
those unfit for surgery, in which MRCP confirms the pres-
ence of bile duct stones. All patients fit for anesthesia are 
prepared for theater and scheduled for surgery on the next 
available list. A few patients with MS associated with sus-
pected cancer due to equivocal cross-sectional imaging and 
three with confirmed Mirizzi type II high up in the porta 
hepatis were referred to a liver surgery unit for management. 
These were judged to require biliary reconstruction.
Patient demographics, American Society of Anesthesiol-
ogists (ASA) classification, clinical presentation, diagnostic 
imaging, operative difficulty grading (Nassar scale) [4–6], 
presence of choledocholithiasis, gallbladder morphology, 
MS type, intraoperative cholangiography results, operative 
time, technical methods utilized, complications, readmis-
sions, hospital stay, and the follow-up period were examined 
in this group.
Open access and a four-port technique is used. An attempt 
to display a critical view of safety is always undertaken. 
Hook dissection of the cystic pedicle and the use of endo-
clips to occlude the cystic structures are not practiced in our 
unit in favor of blunt dissectors and ligation of the cystic 
structures. Once a decision is made that a critical view of 
safety is not possible, alternative approaches are used includ-
ing infundibular identification and dissection, transvesical 
access, and removal of stones or subtotal cholecystectomy 
as a last resort. We perform intraoperative cholangiography 
routinely. Mirizzi type I anomalies are suspected when there 
is difficulty in passing the cholangiography catheter or when 
cannulation is impossible. The cystic duct may be dilated 
and surrounded by inflammatory tissue. Choledochoscopy 
may occasionally have to be used to confirm the presence of 
stones in the intramural part of the cystic duct.
For practical purposes, the authors propose a classifica-
tion into Types IA, IB (where the cystic duct is obliterated) 
and Types II, III, and IV. This is sufficient and includes all 
cases. Types III and IV are very rare and determining the 
exact extent of the involvement of the bile duct circumfer-
ence in the cholecystocholedochal fistula in terms of per-
centages may not be easy to assess.
Type I stones impacted in the intramural cystic duct 
(Fig. 2) may be manipulated into the distal cystic duct using 
two instruments or dislodged using balloon catheters. Once 
removed, completion cholangiography or, if necessary, 
choledochoscopy is performed to exclude bile duct stones. 
The cystic duct stump is then ligated using a tie or an endo-
loop. Impacted stones are fragmented mechanically, or by 
using ultrasound or laser lithotripsy. Repeat cholangiography 
and choledochoscopy are then used to exclude, and retrieve, 
associated bile duct stones. Should the CD be obliterated, 
the surgeon may occasionally decide to perform cholangio-
graphy by direct puncture of the common bile duct in order 
to confirm the integrity of the biliary duct system and the 
absence of stones within it.
Type II MS is suspected when stones are embedded in 
dense inflammatory tissue, when separation of an intact 
Hartman’s Pouch is impossible and when stones are encoun-
tered and dislodged during swab dissection of the area of 
the pedicle. Cholangiography is mandatory, is usually per-
formed through the fistula and may show the presence of 
further stones in the bile duct.
In Type II MS cases, blunt swab dissection may help dis-
lodge the offending stone or expose a cavity where the stone 
is impacted. Transvesical access is used to remove stones, 
avoid proximal dissection, and guard against ductal injury. 
Fragmenting and removing the stone will normally reveal 
the fistula and confirm the diagnosis. Cholangiography is 
Fig. 1  Mirizzi Type I: stone impacted in the proximal cystic duct 
compressing the common bile duct
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then carried out to confirm the integrity of the bile duct and 
to clear any further stones through the fistula or, occasion-
ally, through a separate choledochotomy. In our practice, 
mandatory biliary drainage is achieved by placing a T-Tube 
into the fistula with no attempts to suture or patch the fistula 
(Fig. 3). Bilioenteric anastomosis is not used in uncompli-
cated Type II MS and, in this series was only used once 
when the distal bile duct was very small and the area of the 
fistula was very fibrous, suggesting that a stricture would 
result from the standard approach.
MS Types III and IV are rarely encountered. Should a 
preoperative diagnosis be made (Fig. 4) consideration should 
be given to referring the patient to a specialist liver unit, as 
most patients will require biliary reconstruction.
Long-term follow-up was carried out by reviewing most 
patients annually at the outpatient clinic. In preparation for 
this paper, the available electronic records of the last 52 
cases, outpatient attendances, blood tests any radiological 
investigations that might suggest a biliary problem, and any 
hospital admissions were reviewed in order to ensure com-
plete follow-up.
No ethical approval was required as the one-session 
approach to bile duct stones is the standard management at 
our institution due to the long-term experience and avail-
ability of equipment, in line of guidelines of international 
societies. The consent process emphasized this and included 
counseling when a preoperative diagnosis of MS was 
available. It was recognized that endoscopic management 
had either already been attempted and failed before referral 
or was expected to fail and the fact that the only alternative 
would have been open surgery.
Fig. 2  Cholangiography showing the obstructing stone in Mirizzi 
Type I. The narrow distal CBD demonstrates the obstacle to endo-
scopic stone removal
Fig. 3  T-Tube in position after transfistula exploration and stone 
removal in Mirizzi Type II
Fig. 4  MRCP image showing the typical appearance suggestive of 
Types III and IV Mirizzi Syndrome abnormalities
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The results were analyzed with IBM SPSS 22. Chi-square 
test was performed on categorical variables and a p value 
of < 0.05 was considered statistically significant.
Results
58 cases of MS were encountered (1%). Of these, 38 were 
females (66%). The median age was 55 years (range 29–84). 
43 patients (74%) had an ASA score of 2 or 3 and 53 cases 
(91%) were emergency admissions.
Clinical presentations
83% of our cases presented with current or recent jaundice 
and 9% with derangement of the liver function associated 
with episodes of severe biliary pain, cholangitis, or acute 
cholecystitis. Only two patients presented with acute pan-
creatitis associated with jaundice.
39 patients (67%) in this series had no previous admis-
sions prior to the index presentation. 19 patients (33%) had 
at least one previous admission; with jaundice, acute chol-
ecystitis or acute biliary pain, and derangement of the liver 
function tests. However, only two of these previous admis-
sions were under the care of the treating biliary surgeon. 
They were initially treated conservatively due to a presenta-
tion with vague pain and loss of weight. They were investi-
gated by the gastroenterologists and underwent ERCP show-
ing impacted stones. Stents were inserted, malignancy was 
excluded, and the patients were referred back to the biliary 
firm for surgery. Eleven patients had previous admissions 
to other surgical or medical firms between 2 months and 
2 years prior to presenting to the biliary firm. They were 
treated conservatively either because of uncertain diagnosis, 
old age, or co-morbidity. Another six patients were referred 
for bile duct explorations after previous admissions to other 
hospitals.
Source of referral
40 patients were referred by other surgeons or physicians in 
the hospital and 11 by other hospitals. Only 7 were initially 
admitted under the care of the biliary firm.
The median interval between admission and referral to 
the biliary firm and the median interval from referral to 
surgery are shown in Table 1. More than half the patients 
were operated on within two days after admission and three 
quarters within 5 days.
Radiological investigations
USS was the only radiological investigation in 34 cases 
(59%). The great majority had dilated bile ducts, the CBD 
diameter ranging from 9 to 20 mm. However, only one was 
reported to have bile duct stones and one was reported to 
show a suspicion of MS.
Preoperative MRCP and ERCP are not part of our pro-
tocol for patients with risk factors for bile duct stones who 
are fit for anesthesia. Such patients are normally prepared 
for laparoscopic cholecystectomy with operative cholangio-
graphy and proceed to bile duct exploration when neces-
sary. However, in this series of MS these imaging modalities 
were carried out prior to referral to the biliary firm in 24 
patients including 8 CT scans, 9 MRCPs, and 7 ERCPs in 
six patients. Only 3 CT scans, 3 ERCPs, and 3 MRCP were 
requested after the cases were transferred to the care of the 
biliary firm (Table 2).
Preoperative diagnosis of MS was only possible in 7 
cases (12%) in the whole series. The rest were diagnosed at 
operation where the difficulty grading (Nassar Scale) [4–6] 
was grade IV or V in 54 (93%). The dissection of the cystic 
pedicle was recorded to be difficult in 56 of 58 cases. There 
were significant adhesions around the cystic pedicle or the 
porta hepatis in 45 cases and 5 patients (9%) had confirmed 
cholecystoduodenal fistula. When the pedicle was dissected 
the cystic duct was found wide in 31 cases and cystic duct 
stones had to be removed in 29 cases. In spite of deliberate 
Table 1  Demographic data, N = 58
a Including biliary pain, cholangitis or acute cholecystitis
Females 38 (65.5%)
Age, median (range) 55 (29–84)
ASA classification
 1 12 (20.7%)
 2 or 3 43 (74.1%)
 Not recorded 3 (5.2%)
Emergency admissions 53 (91.4%)
Clinical presentation
 Jaundice 48 (82.7%)
 Deranged  LFTa 5 (8.6%)
 Previous admissions 19 (32.8%)
Source of referral
 Biliary firm admission 7 (12.1%)
 Other surgeon 34 (58.6%)
 Physicians 6 (10.3%)
 Other hospital 11 (19.0%)
Days from admission to referral, mean (range) 3 (0–24)
Days from referral to surgery, mean (range) 2 (0–10)
Referral to surgery interval
 Day 0–Day 1 25 (43.1%)
 Within 2 days 32 (55.2%)
 Within 5 days 44 (75.9%)
 More than 5 days 11 (19.0%)
 Unknown 2 (3.4%)
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attempts it was only possible on dissection to display the 
Critical View of Safety (CVS) in 19% of the cases. Other 
strategies were employed in the majority of cases to reduce 
the risk of ductal injuries including intravesical access to 
the neck of the gallbladder and the infundibular approach. 
Fundus First dissection was necessary in 14 cases.
We found Mirizzi Type IA in 33 cases, Type IB in 7, Type 
II in 16, Type III in one, and Type IV in one case. Mirizzi 
Type IA, IB, and II were significantly associated with opera-
tive difficulty Grade 4 and 5 (p = 0.034). Impacted stones 
needed blunt dissection, using a swab or the suction probe 
to dislodge them, and intraoperative cholangiography (IOC) 
confirmed the diagnosis.
Operative cholangiography was completed before ductal 
exploration in 53/58 cases, 91%. It failed in three Difficulty 
Grade 4 cases and two Grade 5 cases. In total 48 cases had 
CBD stones in addition to the offending stones in the cystic 
duct in Type I or causing the fistula in Type II. (Table 3).
Type IA cases required stone removal using either tran-
scystic exploration (TCE) (21 cases) or a choledochotomy 
(12 cases).
Four Type IB cases and all 16 type II cases required bile 
duct stone removal through choledochotomies. Choledo-
choscopies were performed transfistula in the Type III and 
Type IV cases. They had associated CBD stones removed 
and the patients referred to liver units for bilioenteric 
reconstruction.
The number of CBD stones in this series ranged from 
1–17 (median 1) and their size ranged from 5 to 30 mm 
(median 12 mm).
Biliary drainage was established using a transcystic tube 
in 12 cases or a T-Tube in 28 cases. No drainage was neces-
sary in 16 Type I cases (Table 4). Bilioenteric anastomosis 
was necessary in four cases: two were conversions to open 
surgery: one Type II case with a very fibrous pedicle and a 
narrowed CBD below the fistula and a Type IB case with an 
impacted large stone in the lower CBD. The Type III and the 
Type IV cases were referred to liver surgery units as they 
required further surgery for biliary reconstruction. Type IA, 
IB, and II were not significantly associated with conversion 
to open surgery (p = 0.0576).
The median operating time was 180 min with a mean 
operating time of 3 h and 29 min (range 45–420 min).
Abdominal drains were used in all but one of our cases. 
In many cases, drainage was dictated by the pathology of 
the gallbladder or reflected the difficulty grade. We also 
Table 2  Radiological investigations
Preoperative radiological investigation, N = 58
USS only 34 (58.6%)
Other imaging tests (in 24 patients) Before referral After referral
CT 8 3
MRCP 9 3
ERCP 7 3
Operative or postoperative investigations, N = 58
Operative cholangiography 53 (91.4%)
Operative choledochoscopy 51 (87.9%)
Postoperative cholangiography 33 (56.9%)
Table 3  Operative findings, N = 58
Mirizzi type
 IA 33 (56.9%)
 IB 7 (12.1%)
 II 16 (27.6%)
 III 1 (1.7%)
 IV 1 (1.7%)
Cholecystoduodenal fistula (+ cholecystocolic fistula 
in 1)
5 (8.6%)
Difficulty grading (Nassar scale)
 I 1 (1.7%)
 II 1 (1.7%)
 III 2 (3.4%)
 IV 34 (58.6%)
 V 20 (34.5%)
Critical view of safety achieved 11 (19.0%)
Fundus first dissection 14 (24.1%)
Cystic duct stones 29 (50.0%)
CBD stones in addition to offending stone 48 (82.8%)
Operative time
 Mean [min (range)] 197 (45–420)
 Median (min) 180
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consider abdominal drains mandatory after choledochotomy 
exploration.
Postoperative data
Postoperative morbidity occurred in 29%, including pneu-
monia, wound infections, urinary retention, pancreatitis, 
retained stones, secondary bleeding, and bile leakage. There 
were 10 readmissions in total (17%), two with repeat epi-
sodes. Pain after biliary drain removal caused delayed dis-
charge between 1 and 5 days and 7 readmissions.
Reinterventions were required in six cases. Five patients 
underwent one or more ERCPs and reoperations were even-
tually necessary in three. Endoscopic interventions for 
retained stones were necessary in two patients with Mirizzi 
Type I who had impacted stones intentionally left behind for 
postoperative ERCP. One required 6 attempts and one had 
two attempts before the offending stones were removed. One 
MS Type I patient had a persistent right hepatic duct stric-
ture on postoperative T-Tube cholangiography and required 
an ERCP. Another patient with MS Type II had persistent 
jaundice and bile leakage. Attempted ERCP failed due to an 
associated duodenal stricture and she subsequently had lapa-
roscopic stenting of the CBD stricture. The Mirizzi Type III 
case initially needed an ERCP and stenting for bile leakage 
but appeared to have secondary hemorrhage a week post-
operatively. He subsequently had a laparotomy and biliary 
reconstruction. The Mirizzi Type IV patient was returned 
on the same day to the referring liver unit where he under-
went a successful biliary reconstruction the following day. 
Two deaths occurred as a result of pneumonia; an 81-year-
old man referred 3 weeks after admission under the physi-
cians and failed ERCP and a 78-year-old woman who died 3 
weeks after uneventful surgery. None had technique-related 
complications (Table 5).
Table 4  Operative technique, 
N = 58 Operative data Global results MS IA MS 1B MS II MS III MS IV
N = 58 N = 33 N = 7 N = 16 N = 1 N = 1
Operative cholangiography 53 (91.4%) 32 5 14 1 1
CBD exploration 55 33 4 16 1 1
Transcystic 21 21 0 0 0 0
Choledochotomy/transfistula 34 12 4 16 1 1
None 3 0 3 0 0 0
Biliary drainage
 Transcystic 12 12 0 0 0 0
 T-tube 28 8 3 15 1 1
 None 16 13 3 0 0 0
 Bilioenteric anastomosis 2 0 1 1 0 0
Conversion 2 (3.4%) 0 2 0 0 0
Bilioenteric bypass 2 (3.4%) 0 1 1 0 0
Reconstruction 2(3.4%) 0 0 0 1 1
Table 5  Postoperative data, N = 58
Postoperative data—morbidity, N = 58
Morbidity 17 (29.3%)
 Surgical site infection 3 (5.5%)
 Pancreatitis 1 (1.8%)
 Retained stones 1 (1.8%)
 Bile leakage 1 (1.8%)
 Pain after drain removal 2 (3.6%)
 Secondary hemorrhage 1 (1.8%)
 Pneumonia 2 (3.6%)
 Other 6 (10.3%)
30-day mortality 2 (3.4%)
Clavien–Dindo classification 17 (29.3%)
 I 9 (15.5%)
 II 4 (6.9%)
 III 2 (3.4%)
 IV 0
 V 2 (3.4%)
Readmissions 10 (17.2%)
 Pain after biliary drain removal 7 (12.1%)
 Retained stones 2 (3.4%)
 Acute renal failure 1 (1.8%)
Reintervention 6 (10.3%)
 ERCP 3 (5.1%)
 ERCP followed by reconstruction 1 (1.7%)
 Reconstruction 1 (1.7%)
 Reoperation for CBD stenting 1 (1.7%)
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Outcome parameters
The Median hospital stay was 11 days (3–54 days). 57% had 
only one hospital episode. The mean number of admissions 
in the series was 1.6 admissions per patient. All but two of 
the previous admissions were under the care of other sur-
geons or other hospitals before being referred to the biliary 
unit. The presentation to resolution period was 3 weeks on 
average (1–34) (Table 6).
Three patients were found to have gallbladder cancer 
involving the cystic pedicle and infiltrating the common 
hepatic ducts. Preoperative diagnosis was not made as two 
had had negative preoperative cross-sectional imaging. The 
third patient was only diagnosed on histological examination 
with negative postoperative cross-sectional imaging, sug-
gesting that preoperative diagnosis was unlikely. Cases with 
histological confirmation of gallbladder cancer are usually 
referred to the regional liver unit for assessment and consid-
eration of radical surgery. No such surgery is attempted at 
this unit. However, all three patients in this series had associ-
ated bile duct stones, one had an empyema of the gallblad-
der, and one had a cholecystoduodenal and a cholecystocolic 
fistula with 17 large stones in the bile ducts. Postoperative 
staging confirmed advanced gallblader cancer infiltrating 
the common hepatic duct and peritoneal spread. All were 
judged inoperable, received palliative treatment, and died 
within 6 months.
Long-term follow-up was possible in 52 patients (89.6%), 
between 7 months and 17 years. This was either carried out 
by patients attending the outpatient clinics annually having 
been informed that follow-up was for research purposes or 
by reviewing the electronic hospital records periodically.
Recurrent stones occurred in only one patient 9 years 
after surgery. The stones were cleared endoscopically and 
the patient has had a further 5 years of uneventful follow-up 
since.
Discussion
The surgical approach to some difficult cases of laparo-
scopic cholecystectomy, and whether or not open con-
version becomes necessary, is usually determined by the 
experience of the operating surgeon and his or her ability 
to adapt their dissection strategy and their utilization of 
available instruments and techniques. MS although rare, 
is one of the most complex and challenging pathologies 
encountered during cholecystectomy. The surgeon may 
not, in a large percentage of cases, suspect the presence 
of such a severe abnormality preoperatively. Once the cri-
teria diagnostic of MS are recognized in the course of 
a procedure and the diagnosis is established the surgeon 
would have to make decisions aiming at not only facilitat-
ing the cholecystectomy, dealing with difficult bile duct 
stones, and taking remedial measures for some MS types 
but also avoiding potentially serious complications, mainly 
bile duct injury.
As obstructive jaundice is an important presentation of 
the condition, the great majority of patients who may be 
affected are initially treated endoscopically in an attempt 
to resolve the jaundice and remove what is usually diag-
nosed as an obstructing bile duct stone. However, endo-
scopic clearance usually fails, as the offending stones are 
either in the cystic duct (Type I) or have already eroded 
the common hepatic or the common bile ducts causing a 
cholecystocholedochal fistula (Type II). While endoscopic 
stone clearance may be very difficult, endoscopic stenting 
and the resolution of the jaundice can usually be achieved 
in the majority of cases. In this study, ten patients had had 
ERCP preoperatively, all failing to remove the offending 
stones, and resorting to relieving the jaundice by stenting 
the CBD. In spite of that only three ERCPs made a preop-
erative diagnosis of MS.
A preoperative diagnosis of a Mirizzi abnormality was 
made in another four cases; on MRCP in three cases and 
ultrasound scan in one. However, a preoperative diagnosis 
was not made in fourteen patients who underwent cross-sec-
tional imaging and attempted endoscopic clearance. Seven 
ERCPs were carried out, repeatedly in two cases, alone or 
in addition to nine MRCPs or eleven CT scans.
Kumar et al. [7] suggested that the preoperative diagnosis 
of MS poses a clinical challenge, as the presentation is usu-
ally similar to that of simple choledocholithiasis. Absence of 
jaundice as a presenting symptom (14%) could be explained 
by the occurrence of a fistulating variety of Mirizzi Syn-
drome. Greiasov et al. [8] reported a preoperative diagnosis 
rate of 27% in a large cohort of 284 patients. Following a 
systemic review of ten studies, Antoniou et al. [9] reported 
that studies with a high preoperative diagnosis rate had a 
significantly lower risk for conversion, procedure-related 
Table 6  Outcome parameters
Outcome parameters, N = 58
Median hospital stay, days (range) 11 (3–54)
Number of episodes, mean 1.6 per patient
One episode 33 (56.9%)
Two or more episodes 26 (44.8%)
Presentation to resolution, weeks (range) 3 (1–34)
Recurrent stones 1 (1.7%)
Long-term follow-up (range) 49 (84.4%) 
(3 month–
13 year)
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complications, and reoperation, when compared with stud-
ies with a low preoperative diagnosis rate. However, as a 
diagnosis of MS types II, III, or IV where cholecystobil-
iary fistulas exist is dependent on the extent of bile duct 
involvement, it is difficult to see how an accurate, if any, 
preoperative diagnosis can be reached and a classification 
made. Even where ERCP is carried out routinely, a diagnos-
tic success rate not higher than 50% was reported [10]. All 
published studies have demonstrated that the limits of ERCP 
in MS extend only to diagnosis and stenting with no stone 
removal being possible.
It is clear therefore that, in spite of the perceived advan-
tages, the incidence of preoperative diagnosis is generally 
low. It is much lower in our series due to our policy of pro-
ceeding to operative cholangiography and bile duct explora-
tion in most cases of suspected bile duct stones rather than 
relying on preoperative endoscopic clearance. As the great 
majority of all MS types have associated bile duct stones 
other than the offending stone, choledochoscopy should be 
available. In our series, we used choledochoscopy in 88% 
of the cases.
The definitive diagnosis of MS is likely to be made intra-
operatively in most cases. There should be a high index of 
suspicion when difficult pedicles are encountered in jaun-
diced patients. A wide and thickened cystic duct with or 
without stones can be the first sign of a Type I abnormality. 
Dissection around the body of the gallbladder can safely 
identify the neck of the gallbladder.
Fundus first dissection was carried out in a quarter of 
our cases. However, in order to ensure safe dissection in 
the absence of a clear critical view of safety, this should not 
be attempted in the presence of impacted proximal stones. 
Removal of palpable stone/stones by opening the neck of 
the gallbladder can facilitate safe cystic duct dissection and 
help to prepare it for cholangiography. Blunt dissection is 
the main stay in such cases, with swab dissection being the 
safest method. There is no place for sharp or diathermy hook 
dissection of the cystic pedicle. Failure to develop the pedi-
cle satisfactorily may indicate the presence of a Mirizzi Type 
II or higher. Although we routinely attempt to display the 
critical view of safety it was not possible to achieve that in 
80% of our MS cases (Fig. 5). It is necessary to abandon this 
approach once a large stone is detected at the pedicle, or a 
very contracted gallbladder is encountered. An intravesical 
approach, opening the gallbladder and removing all pedicle 
stones is a safer strategy, preparing the pedicle for the pos-
sibility of a subtotal cholecystectomy.
Although we usually aim at a complete cholecystectomy, 
subtotal cholecystectomy is a valid and safe option subject 
to the experience of the surgeon, the MS type, and whether 
the condition of the tissue of the Hartman’s Pouch would 
allow such an approach. We consider cholangiography to 
be mandatory in all such cases, both to confirm bile duct 
integrity and to exclude CBD stones. Choledochoscopy can 
also help to confirm the integrity of the bile duct and to 
remove bile duct stones.
The difficult surgical management of MS, whether open 
or laparoscopic, is due to the presence of an intense fibrotic 
process and/or communication between the gallbladder 
and the common hepatic duct. The increased incidences 
of cholecystoenteric fistulae, adhesions, CBD stones, and 
gallbladder cancer determine the operative difficulty and, 
subsequently, surgical approach.
Rust et al. [11] suggested that MS may be a contraindica-
tion to laparoscopic cholecystectomy. However, this was a 
very early study (1991) and it assumed that a preoperative 
diagnosis is available. An intraoperative diagnosis is only 
confirmed once the pedicle has been dissected and, in most 
Type II or higher cases, the offending stone(s) are dislodged. 
While the remedial steps necessary may require open sur-
gery, e.g., bilioenteric bypass, this will depend on the sur-
geon’s experience and skills and we do not, therefore, agree 
that MS is a contraindication to laparoscopic surgery. In our 
view an experienced biliary surgeon is able to diagnose MS 
and handle the difficult pedicle laparoscopically. Conversion 
to open surgery will result in the surgeon changing their 
position in relation to the patient, lose the laparoscopic view, 
and the moderating effect of being observed by the assistant, 
have their left hand obscuring most of the operating field 
while holding or attempting to hold the stone and, believ-
ing the stone to be in the Hartman’s Pouch/infundibulum, 
being tempted to dissect proximal to it. This may cause an 
inexperienced surgeon to open the common hepatic duct in 
his or her search of the cystic duct, a recognized mechanism 
of duct injury.
Fig. 5  Blunt pedicle dissection with the absence of critical view of 
safety
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Only a few studies have been published describing expe-
rience with the laparoscopic technique for the treatment of 
MS. These were mostly case reports or case series. There are 
no randomized controlled trials comparing open and laparo-
scopic treatment of MS and these are difficult to conduct due 
to the low incidence of MS and the few centers providing 
laparoscopic treatment for bile duct stones.
Most published studies report high conversion rates. 
Chowbey et al. [12] reported a 22% conversion rate in 27 MS 
patients. Reviews of laparoscopic treatment of MS report a 
cumulative conversion rate up to 36.4% (Yeh et al. [13]) and 
16% overall complication rate with bile duct injury as the 
most common complication [2]. Kumar et al. [7] preferred 
the open approach suggesting that the laparoscopic approach 
is associated with increased incidence of bile duct injury.
Antoniou et al. [9] claimed that the moderate technical 
success rate of the laparoscopic treatment of MS suggests 
that it cannot be recommended as a standard procedure. 
Their systemic review of ten studies revealed a conversion 
rate of 41%.
However, Kamalesh et al. [14] approached MS laparo-
scopically in 20 cases and completed the procedures in 70%, 
in spite of a relatively high incidence of MS Type II (40%) 
and Type III (20%). They recommended the use of subtotal 
cholecystectomy as they did in most of their patients, with 
the remnant of the Hartman Pouch being left and used to 
construct a choledochoplasty. We have resorted to subtotal 
cholecystectomy in only three patients, two Type I and one 
Type III. A transvesical approach to dissection and cholan-
giography may help confirm the presence of ductal defects in 
severe forms such as MS Type IV, once the impacted stone 
has been dislodged (Fig. 6A). This can then be confirmed 
using cholangiography and choledochoscopy (Fig. 6B).
In our view the routine use of subtotal cholecystectomy 
can lead to over-classifying cases as MS when in fact they 
had simpler impacted Hartman pouch or cystic duct stones. 
This “Pseudo-Mirizzi Syndrome” was suggested by Mer-
cado et al. as a possible cause of over-diagnosis of MS and 
of attributing bile duct injury to a Mirizzi abnormality [15]. 
This occurrence will be more frequent if the surgeon does 
not perform cholangiography or choledochoscopy and may 
lead to retained CBD stones. Moreover, in the majority of 
Type II cases, the impacted stone and the inflamed pedicle 
result in friable granular tissue at the pedicle and fistula. It is 
therefore impossible to find any healthy tissue for a subtotal 
cholecystectomy or a choledochoplasty. A choledochoplasty 
was only attempted in our one Type III case and resulted in a 
bile leakage requiring ERCP and stenting. The patient even-
tually went on to have biliary reconstruction. However, we 
agree with Kamalesh et al. [14] in that biliary reconstruction 
is not necessary in the majority of Type II MS.
In our practice, we have used the cholecystocholedochal 
fistula to access the bile duct via choledochoscopy in all 
Type II cases, confirming its integrity and removing any 
further CBD stones. If an occasional additional choledo-
chotomy is done, being necessary to remove other CBD 
stones, primary closure of the choledochotomy and biliary 
drainage by T-tube into the fistula is less invasive and safer 
than a biliary bypass in Type II cases. Chuang et al. [16] 
used the same approach and concluded that what they called 
laparoscopic transfistula bile duct exploration (LTBDE) was 
a simple and safe approach for patients with MS Type II, 
including Csendes Type IV. They recommended that a chole-
dochoscope equipped with lithotripsy should be available. 
They also confirmed that single-port access TBDE is fea-
sible in carefully selected cases. Long-term follow-up and 
large prospective randomized trials are needed to verify the 
findings.
Fig. 6  A Transvesical insertion of the cholangiography catheter: The 
catheter emerged from the proximal CBD into a Type IV Mirizzi 
Syndrome defect once the offending impacted stone was dislodged. 
B Mirizzi Type IV abnormality: the granulation tissue gap resulting 
from erosion by stone (dislodged) is seen between a cholangiography 
catheter in the common hepatic duct and a choledochoscope in the 
distal common bile duct
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Conclusion
In Mirizzi Syndrome Type I, most obstructing stones are in 
the cystic duct/gallbladder neck, making endoscopic clear-
ance very difficult if not impossible. In such cases it is only 
possible to relieve the jaundice by stenting the CBD with 
subsequent stone removal requiring surgery. One-session 
laparoscopic management of MS optimizes the utilization 
of preoperative imaging, reduces the admission to referral 
and surgery to resolution intervals as well as the number of 
treatment sessions. However, the availability of the expertise 
and logistical support necessary for this approach remains 
limited to a relatively small number of centers.
With successful definitive laparoscopic treatment in 89% 
in this series, we believe that MS diagnosed preoperatively 
or at the time of surgery, should not preclude laparoscopy. 
Using optimal techniques, and performed by experienced 
specialized surgeons, the inherent benefits of the laparo-
scopic approach can make it safer than open surgery. The 
anatomical changes specific to MS make it impossible to 
display a critical view of safety in the majority of cases. 
Alternative approaches should be employed to avoid major 
bile duct injury.
This series demonstrates our approach to managing MS 
Type II. The cholecystocholedochal fistula is used in the 
majority of cases to explore the bile duct, which is then 
drained through the fistula with a T-Tube. It is unnecessary 
to perform a bilioenteric bypass in the great majority of such 
cases, thus reducing the morbidity and potential mortality.
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